The first anti-dengue prescription drug in the world will soon be published and available on the market after over seven years of research. And the Filipinos made it.
“It’s not a vaccine, it’s not a herbal supplement. It is a drug that has activity against the virus,” Dr. Rita Grace Alvero said in an interview
“So parang sinasabi natin na pag ininom ito ng pasyente, gagaling ‘yung kanyang signs and symptoms. So i-cure niya talaga yung dengue,” she added.
Alvero said it was designed to help the public.
Dengue cases rose by 86% in 2019 to 414,532 cases, from the 222,849 cases reported from 1 January until 30 November 2018.
In addition, casualties increased from 1,122 in 2018 to 1,546 in 2019 over the same time span.
In 2012, Alvero was inspired to create a drug by the rising dengue cases in the country.
Then Alvero led a Philippine team to finish the drug.
The medicine is developed from tree herbs or endemic plants native to the region, according to the report.
In the first research step, they showed that the medicinal drug was safe and no adverse effects were observed. This will also be subject to further testing to assess its efficacy for the next six months.
Alvero claimed that even for patients who have complications, the medication is 100% successful against dengue.
The Department of Health, for its part, has also expressed its conviction that the new drug will resolve the problem of dengue in the country.
The project is also part of the agency’s Tuklas Lunas programme, funded by the Department of Science and Technology, to create new pharmaceuticals for Filipinos-often affected diseases.